SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-315734
Filing Date
2018-11-01
Accepted
2018-11-01 16:07:31
Documents
96
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d599127d10q.htm 10-Q 1356011
2 EX-10.1 d599127dex101.htm EX-10.1 15132
3 EX-31.1 d599127dex311.htm EX-31.1 11171
4 EX-31.2 d599127dex312.htm EX-31.2 11250
5 EX-32 d599127dex32.htm EX-32 4823
12 GRAPHIC g599127g1031203143717.jpg GRAPHIC 1429
  Complete submission text file 0001193125-18-315734.txt   8958550

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT teva-20180930.xml EX-101.INS 2117574
7 XBRL TAXONOMY EXTENSION SCHEMA teva-20180930.xsd EX-101.SCH 90615
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20180930_cal.xml EX-101.CAL 96313
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20180930_def.xml EX-101.DEF 491130
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20180930_lab.xml EX-101.LAB 617678
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20180930_pre.xml EX-101.PRE 575509
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 181153775
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1